Clinical Trial

Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis

Study acronym: MTX
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 3, 2025 (before its estimated December 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
Psoriasis is a chronic inflammatory dermatoses which include well demarcated scaly erythematous plaques on whole body including scalp role of methotrexate vs tofacitinib is compared in this study
Trial Details
NCT Number NCT07261306
Lead Sponsor Lahore General Hospital
Conditions Psoriasis
Enrollment 75 participants
Start Date 2025-08-29
Primary Completion 2025-12-10 (estimated)
Study Completion 2025-12-25 (estimated)
Updated on ClinicalTrials.gov 2025-12-03